---
title: "Silo Pharma’s PTSD Program Advances as FDA Fast-Tracks Psychedelic Therapies for PTSD | SILO Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/284580361.md"
description: "Silo Pharma’s PTSD Program Advances as FDA Fast-Tracks Psychedelic Therapies for PTSD | SILO Stock News"
datetime: "2026-04-29T05:10:43.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/284580361.md)
  - [en](https://longbridge.com/en/news/284580361.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/284580361.md)
---

# Silo Pharma’s PTSD Program Advances as FDA Fast-Tracks Psychedelic Therapies for PTSD | SILO Stock News

Silo Pharma’s PTSD Program Advances as FDA Fast-Tracks Psychedelic Therapies for PTSD | SILO Stock News

### Related Stocks

- [SILO.US](https://longbridge.com/en/quote/SILO.US.md)

## Related News & Research

- [Bergman: ‘The time is now’ to push for breakthroughs in psychedelic treatments](https://longbridge.com/en/news/286946328.md)
- [Avaí Bio and Austrianova Complete GMP Master Cell Bank, Begin Viral Testing for Cell-Based Klotho Anti-Aging Therapy | AVAI Stock News](https://longbridge.com/en/news/287067719.md)
- [06:31 ETNetherton Syndrome Market Set to Expand During the Forecast Period (2026-2036) as Novel Therapies Enter Development Pipeline | DelveInsight](https://longbridge.com/en/news/286895360.md)
- [4D Molecular Therapeutics Touts Rapid Phase 3 Momentum for Retinal Gene Therapy](https://longbridge.com/en/news/286655317.md)
- [06:50 ETBliss Launches Bliss Pro™, an Accessible Pro-Grade Skincare Line of Next-Gen Ingredients and Treatments](https://longbridge.com/en/news/286898081.md)